We are live on ! Find out more
BSX icon

Boston Scientific

929 hedge funds and large institutions have $60.7B invested in Boston Scientific in 2022 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 325 increasing their positions, 319 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 107 | Existing positions closed: 59

32% more funds holding in top 10

Funds holding in top 10: 22 → 29 (+7)

7% more funds holding

Funds holding: 866 → 929 (+63)

2% more repeat investments, than reductions

Existing positions increased: 325 | Existing positions reduced: 319

0.36% less ownership

Funds ownership: 91.94% → 91.59% (-0.36%)

12% less capital inflows, than outflows

Capital inflows: $2.82B | Capital outflows: $3.19B

33% less call options, than puts

Call options by funds: $203M | Put options by funds: $303M

Holders
929
Holders Change
+63
Holders Change %
+7.27%
% of All Funds
14.89%
Holding in Top 10
29
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+31.82%
% of All Funds
0.46%
New
107
Increased
325
Reduced
319
Closed
59
Calls
$203​M
Puts
$303​M
Net Calls
-⁠$100​M
Net Calls Change
-⁠$77.7​M

BSX Hedge Fund Activity: Q4 2022 in Review

929 of the 6,238 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2022, worth a combined $60.7B — up 19% from $51.1B a quarter earlier.

Buyers outnumbered sellers: 107 funds opened new BSX positions and 59 closed out — a net gain of 48 holders — while 325 added to existing stakes and 319 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $825M. The largest seller was Citadel Advisors, cutting an estimated $345M.

  • 929 institutional investors held Boston Scientific (BSX) as of Q4 2022, up from 866 in Q3 2022.
  • Funds reported $60.7B of Boston Scientific stock for Q4 2022, up 19% quarter-over-quarter.
  • 107 funds opened new Boston Scientific positions in Q4 2022 and 59 closed out, a net change of +48 holders.
  • The largest Boston Scientific buyer in Q4 2022 was Fidelity Investments, an estimated $825M added.
  • The largest Boston Scientific seller in Q4 2022 was Citadel Advisors, an estimated $345M sold.

Based on aggregated 13F filings for Q4 2022.